Clinical Trial Update: Physiological Effect of Non-invasive Photobiomodulation on Cognition and Mood in Older Adults With Subjective Cognitive Impairment [NA]

View source ↗

Summary

Baycrest reports a clinical trial update on non-invasive photobiomodulation to affect cognition and mood in older adults with subjective cognitive decline/impai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subjective Cognitive Decline
• Subjective Cognitive Impairment

Snippet

Sponsor: Baycrest | Conditions: Subjective Cognitive Decline (SCD), Subjective Cognitive Impairment | NA | Status: NOT_YET_RECRUITING